Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Levent Yeniay

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Environmental Toxicology and Pharmacology|April 7, 2024
Blood and tissue levels of persistent organic pollutants and genetic susceptibility in patients with breast cancerİlgen Onat, Rasih Kocagöz, Merve Demirbügen Öz, et al.
Vaccine|March 20, 2022
Immunogenicity of a xenogeneic multi-epitope HER2<sup>+</sup> breast cancer DNA vaccine targeting the dendritic cell restricted antigen-uptake receptor DEC205Aytül Gül, Mert Döşkaya, Hüseyin Can, et al.
Clinical Breast Cancer|May 16, 2025
Biologically Informed Decision-Making for PMRT in pT3N0M0 Luminal Breast Cancers (Protocol MF22-02): International Multicenter Real-World DataAtilla Soran, Melis Bahadir Gultekin, Bhanu Prasad Venkatesulu, et al.
JCO Global Oncology|February 29, 2020
Surgical Trends in Breast Cancer in Turkey: An Increase in Breast-Conserving SurgeryGüldeniz Karadeniz Çakmak, Selman Emiroğlu, Atakan Sezer, et al.
Annals of Surgical Oncology|February 3, 2021
The Effect of Primary Surgery in Patients with De Novo Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-Center, Prospective Registry StudyAtilla Soran, Lutfi Dogan, Arda Isik, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 29, 2025
Poor Prognostic Clinicopathological Features of Young Women with Breast Cancer in the MF18-04 Turkish National Breast Cancer Registry StudyNeslihan Cabıoğlu, Zeliha Türkyılmaz, Enver Özkurt, et al.
Current Oncology (Toronto, Ont.)|October 28, 2025
Locoregional Treatment in De Novo Bone-Only Metastatic Breast Cancer: Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1aAtilla Soran, Berk Göktepe, Berkay Demirors, et al.
Cancer|October 30, 2024
Combined analysis of the MF18-02/MF18-03 NEOSENTITURK studies: ypN-positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is providedMahmut Muslumanoglu, Neslihan Cabioglu, Abdullah Igci, et al.
Annals of Surgical Oncology|December 2, 2024
Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03Neslihan Cabioglu, Hasan Karanlik, Abdullah Igci, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Environmental Toxicology and Pharmacology|April 7, 2024
Blood and tissue levels of persistent organic pollutants and genetic susceptibility in patients with breast cancerİlgen Onat, Rasih Kocagöz, Merve Demirbügen Öz, et al.
Vaccine|March 20, 2022
Immunogenicity of a xenogeneic multi-epitope HER2<sup>+</sup> breast cancer DNA vaccine targeting the dendritic cell restricted antigen-uptake receptor DEC205Aytül Gül, Mert Döşkaya, Hüseyin Can, et al.
Clinical Breast Cancer|May 16, 2025
Biologically Informed Decision-Making for PMRT in pT3N0M0 Luminal Breast Cancers (Protocol MF22-02): International Multicenter Real-World DataAtilla Soran, Melis Bahadir Gultekin, Bhanu Prasad Venkatesulu, et al.
JCO Global Oncology|February 29, 2020
Surgical Trends in Breast Cancer in Turkey: An Increase in Breast-Conserving SurgeryGüldeniz Karadeniz Çakmak, Selman Emiroğlu, Atakan Sezer, et al.
Annals of Surgical Oncology|February 3, 2021
The Effect of Primary Surgery in Patients with De Novo Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-Center, Prospective Registry StudyAtilla Soran, Lutfi Dogan, Arda Isik, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 29, 2025
Poor Prognostic Clinicopathological Features of Young Women with Breast Cancer in the MF18-04 Turkish National Breast Cancer Registry StudyNeslihan Cabıoğlu, Zeliha Türkyılmaz, Enver Özkurt, et al.
Current Oncology (Toronto, Ont.)|October 28, 2025
Locoregional Treatment in De Novo Bone-Only Metastatic Breast Cancer: Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1aAtilla Soran, Berk Göktepe, Berkay Demirors, et al.
Cancer|October 30, 2024
Combined analysis of the MF18-02/MF18-03 NEOSENTITURK studies: ypN-positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is providedMahmut Muslumanoglu, Neslihan Cabioglu, Abdullah Igci, et al.
Annals of Surgical Oncology|December 2, 2024
Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03Neslihan Cabioglu, Hasan Karanlik, Abdullah Igci, et al.
Pageof 3